NCT02443727View on ClinicalTrials.gov

The Role of Oxytocin in the Perception of Faces

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

September 30, 2016

Conditions
Healthy
Interventions
DRUG

Syntocinon (synthetic oxytocin)

Dosage and details described in arm.

OTHER

Placebo

Dosage and details described in arm.

All Listed Sponsors
collaborator

U.S. National Science Foundation

FED

lead

Rodrigo Cardenas

OTHER

NCT02443727 - The Role of Oxytocin in the Perception of Faces | Biotech Hunter | Biotech Hunter